Glatiramer (Copaxone) and Ketamine Therapy | Tovani Health
Copaxone (Glatiramer acetate) (also: Glatopa) — Immunomodulator (MS DMT)
Verdict at Tovani Health
Fully compatible; injection-site reactions are intrinsic.
Glatiramer and ketamine have no clinically significant interaction. Long-standing first-line MS disease-modifying therapy with one of the cleanest safety profiles in MS treatment — no monitoring requirements like fingolimod's first-dose observation or ocrelizumab's infusion reactions. Subcutaneous injection daily or 3x/week. The intrinsic considerations — injection-site reactions and the occasional post-injection systemic reaction (flushing, chest tightness, anxiety lasting ~15 min) — are independent of KAP.
If you take Copaxone regularly and are considering at-home ketamine therapy, the combination is generally safe at therapeutic doses. This page covers the brief pharmacologic context and what we do at intake.
How Copaxone interacts with ketamine
Glatiramer is a synthetic mixture of polypeptides resembling myelin basic protein. The immunomodulatory mechanism shifts T-cell responses away from pro-inflammatory profiles. Peptide drug — no CYP metabolism. No interaction with ketamine.
What we do at intake
Continue as scheduled. Tell us about any post-injection systemic reactions so we can distinguish those from KAP-related sensations.
Bottom line
Glatiramer and ketamine have no clinically significant interaction. Long-standing first-line MS disease-modifying therapy with one of the cleanest safety profiles in MS treatment — no monitoring requirements like fingolimod's first-dose observation or ocrelizumab's infusion reactions. Subcutaneous injection daily or 3x/week. The intrinsic considerations — injection-site reactions and the occasional post-injection systemic reaction (flushing, chest tightness, anxiety lasting ~15 min) — are independent of KAP.
Ready to find out if at-home ketamine fits your situation?
We’ll note that you’re on Copaxone (Glatiramer acetate) at intake. The eligibility check takes 5 minutes and gives you an honest answer about whether at-home ketamine fits your specific situation.
FL and NJ residents only. Benjamin Soffer, DO — Tovani Health.
Clinically reviewed
Reviewed by Benjamin Soffer, DO on May 22, 2026. Dr. Soffer is a board-certified physician (American Board of Internal Medicine) licensed in Florida and New Jersey, prescribing at-home ketamine therapy through Tovani Health.
This page is general information about how this medication interacts with at-home ketamine therapy at Tovani Health. It is not a substitute for medical advice from your prescribing physician about your specific situation. Always discuss medication changes with the doctor who prescribed them.